Histogen Inc. buy krebskrebs
Start price
19.10.20
/
50%
€38.00
Target price
04.11.21
€40.00
Performance (%)
-65.26%
End price
05.11.21
€13.20
Summary
This prediction ended on 05.11.21 with a price of €13.20. The BUY prediction by krebskrebs for Histogen Inc. performed very badly with a performance of -65.26%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Histogen Inc. | - | - | - | - |
| iShares Core DAX® | 1.085% | -0.846% | 12.464% | 58.472% |
| iShares Nasdaq 100 | -1.665% | -3.306% | 1.502% | 84.473% |
| iShares Nikkei 225® | 3.863% | 6.308% | 22.272% | 56.185% |
| iShares S&P 500 | 0.111% | -1.337% | 1.101% | 58.320% |
Comments by krebskrebs for this prediction
In the thread Histogen Inc. diskutieren
In the thread Trading Histogen Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten